Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Faeth Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q4 2021
- Shares held
- 3.55M
- +146.4K (+4.3%) vs. Q4 2021
- Total value
- $8.21M
- −$11.5M (−58.3%) vs. Q4 2021
- New holders
- 11
- 10 more added
- Sold out
- 6
- 15 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 19 | $0 | 0.00% | +1+5.6% | Added |
| FMR LLC | 179 | $0 | 0.00% | +179 | New |
| Royal Bank of Canada | 1,284 | $3.00K | 0.00% | −3,059−70.4% | Reduced |
| Legal & General Group Plc | 1,674 | $4.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,602 | $4.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,110 | $5.00K | 0.00% | −4,311−67.1% | Reduced |
| Amalgamated Bank | 2,516 | $6.00K | 0.00% | +2,516 | New |
| Amalgamated Financial Corp. | 2,516 | $6.00K | 0.00% | +2,516 | New |
| Barclays PLC | 3,394 | $8.00K | 0.00% | +3,394 | New |
| FNY Investment Advisers, LLC | 3,500 | $8.00K | 0.01% | +3,500 | New |
| Banque Cantonale Vaudoise | 3,900 | $9.00K | 0.00% | +3,000+333.3% | Added |
| Tower Research Capital LLC (TRC) | 4,751 | $11.0K | 0.00% | +1,128+31.1% | Added |
| New York State Common Retirement Fund | 5,490 | $13.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 7,003 | $16.0K | 0.00% | −1,780−20.3% | Reduced |
| California State Teachers Retirement System | 9,107 | $21.0K | 0.00% | −2,184−19.3% | Reduced |
| American International Group, Inc. | 10,375 | $24.0K | 0.00% | −730−6.6% | Reduced |
| Morgan Stanley | 11,086 | $25.0K | 0.00% | −25,760−69.9% | Reduced |
| Jane Street Group, LLC | 10,767 | $25.0K | 0.00% | +10,767 | New |
| Deutsche Bank AG | 11,343 | $26.0K | 0.00% | −1,340−10.6% | Reduced |
| Goldman Sachs Group Inc | 12,677 | $29.0K | 0.00% | +1,579+14.2% | Added |
| Raymond James & Associates | 13,000 | $30.0K | 0.00% | +13,000 | New |
| UBS Group AG | 13,618 | $31.0K | 0.00% | −8,784−39.2% | Reduced |
| BFT Financial Group, LLC | 14,845 | $34.0K | 0.01% | +14,845 | New |
| Rhumbline Advisers | 16,169 | $37.0K | 0.00% | −2,725−14.4% | Reduced |
| Bridgeway Capital Management, LLC | 37,900 | $88.0K | 0.00% | +37,900 | New |
| Two Sigma Advisers, LP | 40,900 | $94.0K | 0.00% | +20,900+104.5% | Added |
| Charles Schwab Investment Management Inc | 43,865 | $102.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 48,001 | $110.0K | 0.00% | +22,967+91.7% | Added |
| Millennium Management LLC | 49,744 | $115.0K | 0.00% | −37,546−43.0% | Reduced |
| HighTower Advisors, LLC | 50,229 | $116.0K | 0.00% | +50,229 | New |
| Truist Financial Corp | 50,441 | $117.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 54,089 | $126.0K | 0.00% | −1,358−2.4% | Reduced |
| Nuveen Asset Management, LLC | 52,456 | $133.0K | 0.00% | +909+1.8% | Added |
| Two Sigma Investments, LP | 62,184 | $144.0K | 0.00% | +33,413+116.1% | Added |
| Renaissance Technologies LLC | 83,195 | $192.0K | 0.00% | +83,195 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $231.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 154,161 | $356.0K | 0.00% | −5,700−3.6% | Reduced |
| JPMorgan Chase & Co | 156,365 | $361.0K | 0.00% | −3,413−2.1% | Reduced |
| State Street Corp | 225,572 | $521.0K | 0.00% | +15,280+7.3% | Added |
| Geode Capital Management, LLC | 255,828 | $590.0K | 0.00% | −690−0.3% | Reduced |
| Vanguard Group Inc | 755,950 | $1.75M | 0.00% | +2,255+0.3% | Added |
| BlackRock Inc. | 1,168,011 | $2.70M | 0.00% | −34,718−2.9% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,980−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,804−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −772−100.0% | Sold out |
| Investment Research & Advisory Group, Inc. | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |